HCV NS4A/modified NS3 polypeptides and uses thereof
US10267803B2 · kind B2 · utility
0Cited by
6References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2015 |
| Grant date | Apr 23, 2019 |
| Priority date | — |
| Expiry date | Jun 22, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2469/20
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Modified hepatitis C virus polypeptides are described. The polypeptides include the HCV NS4a domain and modified NS3 domain. The polypeptides retain conformational epitopes. HCV immunoassays including the polypeptides are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.